The effects of a single dose of oxytocin on working memory in schizophrenia

Schizophrenia Research

Volumn 162, Issue 1-3, 2015, Pages 62-63

  Michalopoulou, Panayiota G ^a   Averbeck, Bruno B ^b   Kalpakidou, Anastasia K ^a   Evans, Simon ^c   Bobin, Tracey ^a   Kapur, Shitij ^a   Shergill, Sukhwinder S ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^c UNIVERSITY OF SUSSEX   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ATYPICAL ANTIPSYCHOTIC AGENT; CHLORPROMAZINE; NEUROLEPTIC AGENT; OXYTOCIN; PLACEBO; SODIUM CHLORIDE; NOOTROPIC AGENT;

ABSENCE OF SIDE EFFECTS; ADULT; CLINICAL ARTICLE; CLINICAL ASSESSMENT TOOL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DEMOGRAPHY; DIGIT SPAN; DIGIT SYMBOL CODING; DIGITS BACKWARD; DIGITS FORWARD; DISEASE DURATION; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DSM-IV; EXECUTIVE FUNCTION; GABAERGIC TRANSMISSION; HUMAN; INFORMATION STORAGE; INFORMATION SYSTEM; LETTER; LOW DRUG DOSE; MALE; NEUROTRANSMISSION; OUTCOME ASSESSMENT; POSITIVE AND NEGATIVE SYNDROME SCALE; PREFRONTAL CORTEX; PRIORITY JOURNAL; SCHIZOPHRENIA; SENSITIVITY AND SPECIFICITY; SINGLE DRUG DOSE; TREATMENT DURATION; TREATMENT OUTCOME; WORKING MEMORY; ADOLESCENT; DRUG EFFECTS; MIDDLE AGED; PSYCHOLOGIC TEST; PSYCHOLOGICAL RATING SCALE; PSYCHOLOGY; RANDOMIZED CONTROLLED TRIAL; SHORT TERM MEMORY; YOUNG ADULT;

ADOLESCENT; ADULT; ANTIPSYCHOTIC AGENTS; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; HUMANS; MALE; MEMORY, SHORT-TERM; MIDDLE AGED; NOOTROPIC AGENTS; OXYTOCIN; PSYCHIATRIC STATUS RATING SCALES; PSYCHOLOGICAL TESTS; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84923254405     PISSN: 09209964     EISSN: 15732509     Source Type: Journal    
DOI: 10.1016/j.schres.2014.12.029     Document Type: Letter

References (10)

1. Averbeck B.B., Bobin T., Evans S., Shergill S.S. Emotion recognition and oxytocin in patients with schizophrenia. Psychol. Med. 2012, 42(2):259-266.
2. Barch D.M., Smith E. The cognitive neuroscience of working memory: relevance to CNTRICS and schizophrenia. Biol. Psychiatry 2008, 64(1):11-17.
3. Baskerville T.A., Douglas A.J. Dopamine and oxytocin interactions underlying behaviors: potential contributions to behavioral disorders. CNS Neurosci. Ther. 2010, 16(3):e92-e123.
4. Chini B., Leonzino M., Braida D., Sala M. Learning about oxytocin: pharmacologic and behavioural issues. Biol. Psychiatry 2014, 76(5):360-366.
5. Crowe S.F. Does the letter number sequencing task measure anything more than digit span?. Assessment 2000, 7(2):113-117.
6. Feifel D., Macdonald K., Cobb P., Minassian A. Adjunctive intranasal oxytocin improves verbal memory in people with schizophrenia. Schizophr. Res. 2012, 139(1-3):207-210.
7. Huber D., Veinante P., Stoop R. Vasopressin and oxytocin excite distinct neuronal populations in the central amygdala. Science 2005, 308(5719):245-248.
8. Kim J., Glahn D.C., Nuechterlein K.H., Cannon T.D. Maintenance and manipulation of information in schizophrenia: further evidence for impairment in the central executive component of working memory. Schizophr. Res. 2004, 68(2-3):173-187.
9. Lewis D.A., Hashimoto T., Volk D.W. Cortical inhibitory neurons and schizophrenia. Nat. Rev. Neurosci. 2005, 6(4):312-324.
10. Smeltzer M.D., Curtis J.T., Aragona T., Brandon B.J., Wang Z. Dopamine, oxytocin, and vasopressin receptor binding in the medial prefrontal cortex of monogamous and promiscuous voles. Neurosci. Lett. 2006, 394(2):146-151.